chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site erythema, Injection site pruritus, Injection site warmth, Pyrexia
Clinical narrative: Headache; swelling on the injection site; injection site warmth; injection site redness; injection site itching; slight fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-May-2021 and was forwarded to Moderna on 12-May-2021.    This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (slight fever), HEADACHE (Headache), SWELLING (swelling on the injection site), INJECTION SITE WARMTH (injection site warmth) and INJECTION SITE ERYTHEMA (injection site redness) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RAMIPRIL (TENAPRIL) for an unknown indication.   On 08-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced PYREXIA (slight fever). On 09-May-2021, the patient experienced HEADACHE (Headache), SWELLING (swelling on the injection site), INJECTION SITE WARMTH (injection site warmth), INJECTION SITE ERYTHEMA (injection site redness) and INJECTION SITE PRURITUS (injection site itching). At the time of the report, PYREXIA (slight fever), HEADACHE (Headache), SWELLING (swelling on the injection site), INJECTION SITE WARMTH (injection site warmth), INJECTION SITE ERYTHEMA (injection site redness) and INJECTION SITE PRURITUS (injection site itching) outcome was unknown.            No treatment medication were not reported   This case was linked to MOD-2021-119054 (Patient Link).   Reporter did not allow further contact
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Headache; swelling on the injection site; injection site warmth; injection site redness; injection site itching; slight fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-May-2021 and was forwarded to Moderna on 12-May-2021.    This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (slight fever), HEADACHE (Headache), SWELLING (swelling on the injection site), INJECTION SITE WARMTH (injection site warmth) and INJECTION SITE ERYTHEMA (injection site redness) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RAMIPRIL (TENAPRIL) for an unknown indication.   On 08-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced PYREXIA (slight fever). On 09-May-2021, the patient experienced HEADACHE (Headache), SWELLING (swelling on the injection site), INJECTION SITE WARMTH (injection site warmth), INJECTION SITE ERYTHEMA (injection site redness) and INJECTION SITE PRURITUS (injection site itching). At the time of the report, PYREXIA (slight fever), HEADACHE (Headache), SWELLING (swelling on the injection site), INJECTION SITE WARMTH (injection site warmth), INJECTION SITE ERYTHEMA (injection site redness) and INJECTION SITE PRURITUS (injection site itching) outcome was unknown.            No treatment medication were not reported   This case was linked to MOD-2021-119054 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 1st dose given over 42 days ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose given over 42 days ago) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose given over 42 days ago). On 27-Mar-2021, PRODUCT DOSE OMISSION ISSUE (1st dose given over 42 days ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products were not provided.  Treatment medications were not reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Myalgia
Clinical narrative: Feeling cold; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feeling cold) and MYALGIA (Sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025821A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced FEELING COLD (Feeling cold) and MYALGIA (Sore arm). At the time of the report, FEELING COLD (Feeling cold) and MYALGIA (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Follow-up information received on 11-JUN-2021. Updated event outcome from unknown to recovered for the events FEELING COLD (feeling cold) and MYALGIA (Sore arm).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Drug hypersensitivity, Dry skin, Erythema, Fatigue
Clinical narrative: If she had allergic reactions to both shots; she didn't feel well; tired; memory issues; lips got tingly; lips got swollen; face was bright red; face was swollen; She had the munchies; She had nasal congestion/sounded congested; she felt manic (hyper) for 12 hours; arm was sore; got confused; spacy; dry patches on her skin at her ankle and the side of her head; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA ORAL (lips got tingly), LIP SWELLING (lips got swollen), ERYTHEMA (face was bright red), SWELLING FACE (face was swollen) and HUNGER (She had the munchies) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Feb-2021, the patient experienced PARAESTHESIA ORAL (lips got tingly), LIP SWELLING (lips got swollen), ERYTHEMA (face was bright red), SWELLING FACE (face was swollen), HUNGER (She had the munchies), NASAL CONGESTION (She had nasal congestion/sounded congested), MANIA (she felt manic (hyper) for 12 hours), PAIN IN EXTREMITY (arm was sore), CONFUSIONAL STATE (got confused), FEELING ABNORMAL (spacy), MEMORY IMPAIRMENT (memory issues) and FATIGUE (tired).   On 12-Feb-2021, the patient experienced MALAISE (she didn't feel well). In February 2021, the patient experienced DRY SKIN (dry patches on her skin at her ankle and the side of her head).   On an unknown date, the patient experienced DRUG HYPERSENSITIVITY (If she had allergic reactions to both shots).   On 11-Feb-2021, ERYTHEMA (face was bright red), SWELLING FACE (face was swollen), CONFUSIONAL STATE (got confused) and FEELING ABNORMAL (spacy) outcome was unknown.   On 12-Mar-2021, MALAISE (she didn't feel well) outcome was unknown.   On 19-Mar-2021, HUNGER (She had the munchies) and MANIA (she felt manic (hyper) for 12 hours) outcome was unknown.   On 19-Apr-2021, FATIGUE (tired) outcome was unknown.   At the time of the report, DRY SKIN (dry patches on her skin at her ankle and the side of her head), MEMORY IMPAIRMENT (memory issues) and DRUG HYPERSENSITIVITY (If she had allergic reactions to both shots) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-089812, MOD21-089813, US-MODERNATX, INC.-MOD-2021-123936 (E2B Linked Report).  This case was linked to MOD-2021-123493, MOD-2021-123493 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes:  On 12-May-2021: TCR document; Sender's Comments:  MOD21-089812:Same reporter MOD21-089813:Same reporter US-MODERNATX, INC.-MOD-2021-123936:crosslinked
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hunger, Lip swelling, Malaise, Mania
Clinical narrative: If she had allergic reactions to both shots; she didn't feel well; tired; memory issues; lips got tingly; lips got swollen; face was bright red; face was swollen; She had the munchies; She had nasal congestion/sounded congested; she felt manic (hyper) for 12 hours; arm was sore; got confused; spacy; dry patches on her skin at her ankle and the side of her head; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA ORAL (lips got tingly), LIP SWELLING (lips got swollen), ERYTHEMA (face was bright red), SWELLING FACE (face was swollen) and HUNGER (She had the munchies) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Feb-2021, the patient experienced PARAESTHESIA ORAL (lips got tingly), LIP SWELLING (lips got swollen), ERYTHEMA (face was bright red), SWELLING FACE (face was swollen), HUNGER (She had the munchies), NASAL CONGESTION (She had nasal congestion/sounded congested), MANIA (she felt manic (hyper) for 12 hours), PAIN IN EXTREMITY (arm was sore), CONFUSIONAL STATE (got confused), FEELING ABNORMAL (spacy), MEMORY IMPAIRMENT (memory issues) and FATIGUE (tired).   On 12-Feb-2021, the patient experienced MALAISE (she didn't feel well). In February 2021, the patient experienced DRY SKIN (dry patches on her skin at her ankle and the side of her head).   On an unknown date, the patient experienced DRUG HYPERSENSITIVITY (If she had allergic reactions to both shots).   On 11-Feb-2021, ERYTHEMA (face was bright red), SWELLING FACE (face was swollen), CONFUSIONAL STATE (got confused) and FEELING ABNORMAL (spacy) outcome was unknown.   On 12-Mar-2021, MALAISE (she didn't feel well) outcome was unknown.   On 19-Mar-2021, HUNGER (She had the munchies) and MANIA (she felt manic (hyper) for 12 hours) outcome was unknown.   On 19-Apr-2021, FATIGUE (tired) outcome was unknown.   At the time of the report, DRY SKIN (dry patches on her skin at her ankle and the side of her head), MEMORY IMPAIRMENT (memory issues) and DRUG HYPERSENSITIVITY (If she had allergic reactions to both shots) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-089812, MOD21-089813, US-MODERNATX, INC.-MOD-2021-123936 (E2B Linked Report).  This case was linked to MOD-2021-123493, MOD-2021-123493 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes:  On 12-May-2021: TCR document; Sender's Comments:  MOD21-089812:Same reporter MOD21-089813:Same reporter US-MODERNATX, INC.-MOD-2021-123936:crosslinked
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Nasal congestion, Pain in extremity, Paraesthesia oral, Swelling face
Clinical narrative: If she had allergic reactions to both shots; she didn't feel well; tired; memory issues; lips got tingly; lips got swollen; face was bright red; face was swollen; She had the munchies; She had nasal congestion/sounded congested; she felt manic (hyper) for 12 hours; arm was sore; got confused; spacy; dry patches on her skin at her ankle and the side of her head; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA ORAL (lips got tingly), LIP SWELLING (lips got swollen), ERYTHEMA (face was bright red), SWELLING FACE (face was swollen) and HUNGER (She had the munchies) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Feb-2021, the patient experienced PARAESTHESIA ORAL (lips got tingly), LIP SWELLING (lips got swollen), ERYTHEMA (face was bright red), SWELLING FACE (face was swollen), HUNGER (She had the munchies), NASAL CONGESTION (She had nasal congestion/sounded congested), MANIA (she felt manic (hyper) for 12 hours), PAIN IN EXTREMITY (arm was sore), CONFUSIONAL STATE (got confused), FEELING ABNORMAL (spacy), MEMORY IMPAIRMENT (memory issues) and FATIGUE (tired).   On 12-Feb-2021, the patient experienced MALAISE (she didn't feel well). In February 2021, the patient experienced DRY SKIN (dry patches on her skin at her ankle and the side of her head).   On an unknown date, the patient experienced DRUG HYPERSENSITIVITY (If she had allergic reactions to both shots).   On 11-Feb-2021, ERYTHEMA (face was bright red), SWELLING FACE (face was swollen), CONFUSIONAL STATE (got confused) and FEELING ABNORMAL (spacy) outcome was unknown.   On 12-Mar-2021, MALAISE (she didn't feel well) outcome was unknown.   On 19-Mar-2021, HUNGER (She had the munchies) and MANIA (she felt manic (hyper) for 12 hours) outcome was unknown.   On 19-Apr-2021, FATIGUE (tired) outcome was unknown.   At the time of the report, DRY SKIN (dry patches on her skin at her ankle and the side of her head), MEMORY IMPAIRMENT (memory issues) and DRUG HYPERSENSITIVITY (If she had allergic reactions to both shots) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-089812, MOD21-089813, US-MODERNATX, INC.-MOD-2021-123936 (E2B Linked Report).  This case was linked to MOD-2021-123493, MOD-2021-123493 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes:  On 12-May-2021: TCR document; Sender's Comments:  MOD21-089812:Same reporter MOD21-089813:Same reporter US-MODERNATX, INC.-MOD-2021-123936:crosslinked
Sex: F
Vaccine: COVID19
Symptoms: Alcohol problem, Anxiety, Dizziness, Dyspnoea, Euphoric mood
Clinical narrative: calm mind; feeling faint; drinking too much  after her vaccination in April. Patient reports she drank after her vaccine to relieve stress and be sedated; anxiety related to vaccine; stress related to vaccine; rapid heartbeat, elevated heart rate; loss of breath, difficulty breathing, inability to use treadmill for walking exercise due to loss of breath; feeling high, feeling of adrenalin rush through body; whole body feeling alert; This spontaneous case was reported by a patient and describes the occurrence of HEART RATE INCREASED (rapid heartbeat, elevated heart rate), DYSPNOEA (loss of breath, difficulty breathing, inability to use treadmill for walking exercise due to loss of breath), EUPHORIC MOOD (feeling high, feeling of adrenalin rush through body), HYPERVIGILANCE (whole body feeling alert) and FEELING OF RELAXATION (calm mind) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. In April 2021, the patient experienced HEART RATE INCREASED (rapid heartbeat, elevated heart rate), DYSPNOEA (loss of breath, difficulty breathing, inability to use treadmill for walking exercise due to loss of breath), EUPHORIC MOOD (feeling high, feeling of adrenalin rush through body), HYPERVIGILANCE (whole body feeling alert), FEELING OF RELAXATION (calm mind), DIZZINESS (feeling faint), ALCOHOL PROBLEM (drinking too much  after her vaccination in April. Patient reports she drank after her vaccine to relieve stress and be sedated), ANXIETY (anxiety related to vaccine) and STRESS (stress related to vaccine). At the time of the report, HEART RATE INCREASED (rapid heartbeat, elevated heart rate), DYSPNOEA (loss of breath, difficulty breathing, inability to use treadmill for walking exercise due to loss of breath), EUPHORIC MOOD (feeling high, feeling of adrenalin rush through body), HYPERVIGILANCE (whole body feeling alert), FEELING OF RELAXATION (calm mind), DIZZINESS (feeling faint), ALCOHOL PROBLEM (drinking too much  after her vaccination in April. Patient reports she drank after her vaccine to relieve stress and be sedated), ANXIETY (anxiety related to vaccine) and STRESS (stress related to vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: elevated (High) Patient reports her heart rate is normally below 60 and has been elevated to 81-87 bpm..         No treatment and concomitant drug information provided   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Feeling of relaxation, Heart rate, Heart rate increased, Hypervigilance, Stress
Clinical narrative: calm mind; feeling faint; drinking too much  after her vaccination in April. Patient reports she drank after her vaccine to relieve stress and be sedated; anxiety related to vaccine; stress related to vaccine; rapid heartbeat, elevated heart rate; loss of breath, difficulty breathing, inability to use treadmill for walking exercise due to loss of breath; feeling high, feeling of adrenalin rush through body; whole body feeling alert; This spontaneous case was reported by a patient and describes the occurrence of HEART RATE INCREASED (rapid heartbeat, elevated heart rate), DYSPNOEA (loss of breath, difficulty breathing, inability to use treadmill for walking exercise due to loss of breath), EUPHORIC MOOD (feeling high, feeling of adrenalin rush through body), HYPERVIGILANCE (whole body feeling alert) and FEELING OF RELAXATION (calm mind) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. In April 2021, the patient experienced HEART RATE INCREASED (rapid heartbeat, elevated heart rate), DYSPNOEA (loss of breath, difficulty breathing, inability to use treadmill for walking exercise due to loss of breath), EUPHORIC MOOD (feeling high, feeling of adrenalin rush through body), HYPERVIGILANCE (whole body feeling alert), FEELING OF RELAXATION (calm mind), DIZZINESS (feeling faint), ALCOHOL PROBLEM (drinking too much  after her vaccination in April. Patient reports she drank after her vaccine to relieve stress and be sedated), ANXIETY (anxiety related to vaccine) and STRESS (stress related to vaccine). At the time of the report, HEART RATE INCREASED (rapid heartbeat, elevated heart rate), DYSPNOEA (loss of breath, difficulty breathing, inability to use treadmill for walking exercise due to loss of breath), EUPHORIC MOOD (feeling high, feeling of adrenalin rush through body), HYPERVIGILANCE (whole body feeling alert), FEELING OF RELAXATION (calm mind), DIZZINESS (feeling faint), ALCOHOL PROBLEM (drinking too much  after her vaccination in April. Patient reports she drank after her vaccine to relieve stress and be sedated), ANXIETY (anxiety related to vaccine) and STRESS (stress related to vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: elevated (High) Patient reports her heart rate is normally below 60 and has been elevated to 81-87 bpm..         No treatment and concomitant drug information provided   Reporter did not allow further contact
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site warmth
Clinical narrative: non-visible lump with heat, on the shoulder of the right arm around the injection site; non-visible lump with heat, on the shoulder of the right arm around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (non-visible lump with heat, on the shoulder of the right arm around the injection site) and VACCINATION SITE WARMTH (non-visible lump with heat, on the shoulder of the right arm around the injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     Concomitant products included VITAMIN 15 for an unknown indication.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced VACCINATION SITE MASS (non-visible lump with heat, on the shoulder of the right arm around the injection site) and VACCINATION SITE WARMTH (non-visible lump with heat, on the shoulder of the right arm around the injection site). At the time of the report, VACCINATION SITE MASS (non-visible lump with heat, on the shoulder of the right arm around the injection site) and VACCINATION SITE WARMTH (non-visible lump with heat, on the shoulder of the right arm around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Slight soreness; Slight amout of soreness in left upper arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Slight amout of soreness in left upper arm) and MYALGIA (Slight soreness) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 012A21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure (High). Concurrent medical conditions included Penicillin allergy, Calcium, Drug allergy (codeine), Drug allergy (Premarin), Drug allergy (Prevacid) and Drug allergy (toprop xl). Concomitant products included AMLODIPINE and HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) for Blood pressure high, ASA for Heart disease, unspecified.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced MYALGIA (Slight amout of soreness in left upper arm). On 24-Mar-2021, the patient experienced MYALGIA (Slight soreness). The patient was treated with PARACETAMOL (TYLENOL) (oral) ongoing from 24-Feb-2021 for Myalgia, at a dose of 600 mg,POX1. On 26-Feb-2021, MYALGIA (Slight amout of soreness in left upper arm) had resolved. On 25-Mar-2021, MYALGIA (Slight soreness) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up information received on 16-JUN-2021 contains non-significant information.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dysgeusia, Headache, Injection site pain
Clinical narrative: odd nasty taste in my mouth; tummy was upset; headache; really felt the injection this time; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (odd nasty taste in my mouth), ABDOMINAL DISCOMFORT (tummy was upset), HEADACHE (headache) and INJECTION SITE PAIN (really felt the injection this time) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (odd nasty taste in my mouth), ABDOMINAL DISCOMFORT (tummy was upset), HEADACHE (headache) and INJECTION SITE PAIN (really felt the injection this time). At the time of the report, DYSGEUSIA (odd nasty taste in my mouth), ABDOMINAL DISCOMFORT (tummy was upset), HEADACHE (headache) and INJECTION SITE PAIN (really felt the injection this time) had resolved.            No Concomitants included. No Treatment was included.  Action taken with mRNA-1273 in response to the drug was not applicable.   This case was linked to MOD-2021-133792 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Chills; Fever between 100.4 to 100.6 F; Body aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 13-May-2021 and was forwarded to Moderna on 13-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever between 100.4 to 100.6 F) and MYALGIA (Body aches) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever between 100.4 to 100.6 F) and MYALGIA (Body aches). On 25-Mar-2021, CHILLS (Chills), PYREXIA (Fever between 100.4 to 100.6 F) and MYALGIA (Body aches) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatments were taken because patient was allergic to Tylenol, so said she took it easy and put cold compress in her head.   This case was linked to MOD-2021-135386 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.   The action taken with mRNA 1273 with the events was considered as not applicable.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: The Follow up document was received on18-MAY-2021 and patient date of birth was removed.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Feeling abnormal, Headache, Nausea
Clinical narrative: Headache; missed her second dose; COVID arm went down her elbow; Nauseous; Deep pain in the vaccine area intermittently; Felt dizzy; Her head was feeling funny; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-May-2021 and was forwarded to Moderna on 17-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy), FEELING ABNORMAL (Her head was feeling funny), PRODUCT DOSE OMISSION ISSUE (missed her second dose), ARTHRALGIA (COVID arm went down her elbow) and NAUSEA (Nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIZZINESS (Felt dizzy), FEELING ABNORMAL (Her head was feeling funny), NAUSEA (Nauseous) and VACCINATION SITE PAIN (Deep pain in the vaccine area intermittently). On 27-Mar-2021, the patient experienced ARTHRALGIA (COVID arm went down her elbow). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed her second dose) and HEADACHE (Headache). The patient was treated with HYDROCORTISONE at a dose of 1 dosage form. On 03-Apr-2021, ARTHRALGIA (COVID arm went down her elbow) had resolved. At the time of the report, DIZZINESS (Felt dizzy), FEELING ABNORMAL (Her head was feeling funny), NAUSEA (Nauseous), VACCINATION SITE PAIN (Deep pain in the vaccine area intermittently) and HEADACHE (Headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed her second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  .   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Vaccination site pain
Clinical narrative: Headache; missed her second dose; COVID arm went down her elbow; Nauseous; Deep pain in the vaccine area intermittently; Felt dizzy; Her head was feeling funny; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-May-2021 and was forwarded to Moderna on 17-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy), FEELING ABNORMAL (Her head was feeling funny), PRODUCT DOSE OMISSION ISSUE (missed her second dose), ARTHRALGIA (COVID arm went down her elbow) and NAUSEA (Nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIZZINESS (Felt dizzy), FEELING ABNORMAL (Her head was feeling funny), NAUSEA (Nauseous) and VACCINATION SITE PAIN (Deep pain in the vaccine area intermittently). On 27-Mar-2021, the patient experienced ARTHRALGIA (COVID arm went down her elbow). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed her second dose) and HEADACHE (Headache). The patient was treated with HYDROCORTISONE at a dose of 1 dosage form. On 03-Apr-2021, ARTHRALGIA (COVID arm went down her elbow) had resolved. At the time of the report, DIZZINESS (Felt dizzy), FEELING ABNORMAL (Her head was feeling funny), NAUSEA (Nauseous), VACCINATION SITE PAIN (Deep pain in the vaccine area intermittently) and HEADACHE (Headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed her second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  .   Reporter did not allow further contact
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Fever 100.5; Body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 100.5), MYALGIA (Body ache) and HEADACHE (Headache) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced PYREXIA (Fever 100.5), MYALGIA (Body ache) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever 100.5), MYALGIA (Body ache) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered past the expiration/beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered past the expiration/beyond use date) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered past the expiration/beyond use date). On 17-May-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered past the expiration/beyond use date) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. The vaccine was kept in the refrigerator at a normal refrigerator temperature for 33 days. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow-up received on 18-MAY-2021 contains reporter information.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Palpitations
Clinical narrative: Still feels like heart racing at times; felt a rush to the head,felt a rush of dizziness,feels like may faint; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt a rush to the head,felt a rush of dizziness,feels like may faint) and PALPITATIONS (Still feels like heart racing at times) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 026B21A) for COVID-19 immunisation.     Concurrent medical conditions included Caffeine allergy (very sensitive to caffeine and stays away from these because makes heart race) and Drug allergy (very sensitive to Sudafed, take child's dosage in many medications due to sensitivity.).   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced DIZZINESS (felt a rush to the head,felt a rush of dizziness,feels like may faint). On an unknown date, the patient experienced PALPITATIONS (Still feels like heart racing at times). At the time of the report, DIZZINESS (felt a rush to the head,felt a rush of dizziness,feels like may faint) and PALPITATIONS (Still feels like heart racing at times) outcome was unknown.            Age of the patient was reported as over 60 years old.  No concomitant medications were reported. No corrective treatment was provided.  When patient got second dose, felt a rush to the head. The second day after second dose, patient felt a rush of dizziness and feels like may faint. Still feels like heart racing at times.   This case was linked to MOD21-091252 (E2B Linked Report). This case was linked to MOD-2021-139244 (Patient Link).; Sender's Comments:  MOD21-091252:
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Mixed series vaccine given to patient.; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Mixed series vaccine given to patient.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 17-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose and first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On an unknown date, received dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to at an unspecified dose. On 17-May-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Mixed series vaccine given to patient.). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Mixed series vaccine given to patient.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   co-suspect OML required after MR
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pain in extremity, Vaccination site erythema
Clinical narrative: Pain in the arm of injection; Redness in the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm of injection) and VACCINATION SITE ERYTHEMA (Redness in the site of injection) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (discharged on 25Mar2021) on 12-Mar-2021. Concurrent medical conditions included Arthritis and Loss of smell (started when diagnosed with COVID and not after the first dose of the vaccine) since 12-Mar-2021. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm of injection) and VACCINATION SITE ERYTHEMA (Redness in the site of injection). On 07-May-2021, PAIN IN EXTREMITY (Pain in the arm of injection) and VACCINATION SITE ERYTHEMA (Redness in the site of injection) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, COVID-19: positive (Positive) COVID-19 positive.         Doctor took an X-Ray of patient's nose a week ago and results are pending.  Treatment medication information was provided, however patient was not sure if it was Tylenol or naproxen.   This case was linked to MOD-2021-143359, MOD-2021-142705 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: No new information was received. On 01-Jul-2021: report - X-Ray done. Sense of smell has not come back completely.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: 2nd Vaccination injected with Jansson COVID19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (2nd Vaccination injected with Jansson COVID19 Vaccine) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 203A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (2nd Vaccination injected with Jansson COVID19 Vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (2nd Vaccination injected with Jansson COVID19 Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications include high blood pressure medications , diabetes medications, chronic pain medications.  Received Jansson COVID19 Vaccine for 2nd injection after receiving the Moderna Vaccine for 1st injection.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Skin exfoliation
Clinical narrative: Skin started pealing; Fever; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Skin started pealing) and PYREXIA (Fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No medical history reported by the reporter.  Concomitant products included LOSARTAN, TRIAMCINOLONE, CALCIUM and VITAMIN D NOS for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced PYREXIA (Fever). On 06-May-2021, the patient experienced SKIN EXFOLIATION (Skin started pealing). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-May-2021, PYREXIA (Fever) had resolved. At the time of the report, SKIN EXFOLIATION (Skin started pealing) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient received vaccine to her Left Dominant upper arm
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Pruritus
Clinical narrative: pruritis; erythema; This spontaneous case was reported by a non-health professional and describes the occurrence of PRURITUS (pruritis) and ERYTHEMA (erythema) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Adhesive plaster sensitivity and Hypersensitivity.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PRURITUS (pruritis) and ERYTHEMA (erythema). The patient was treated with ACETAMINOPHEN for Fever, at an unspecified dose and frequency. On 11-Apr-2021, PRURITUS (pruritis) had resolved. At the time of the report, ERYTHEMA (erythema) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.9 degree Celsius High.         This case was linked to MOD-2021-053254 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Blister, Burning sensation, Eczema, Pruritus
Clinical narrative: pimple size nodules; blister sacks with extreme itching on 3 fingers; looks like eczema on both hands; constantly itching and burning; constantly itching and burning; This spontaneous case was reported by a patient and describes the occurrence of ACNE (pimple size nodules), BLISTER (blister sacks with extreme itching on 3 fingers), ECZEMA (looks like eczema on both hands), PRURITUS (constantly itching and burning) and BURNING SENSATION (constantly itching and burning) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2021, the patient experienced ACNE (pimple size nodules), BLISTER (blister sacks with extreme itching on 3 fingers), ECZEMA (looks like eczema on both hands), PRURITUS (constantly itching and burning) and BURNING SENSATION (constantly itching and burning). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ACNE (pimple size nodules), BLISTER (blister sacks with extreme itching on 3 fingers), ECZEMA (looks like eczema on both hands), PRURITUS (constantly itching and burning) and BURNING SENSATION (constantly itching and burning) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-148313 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Arm was sore; little headache the second day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore) and HEADACHE (little headache the second day) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore) and HEADACHE (little headache the second day). At the time of the report, PAIN IN EXTREMITY (Arm was sore) and HEADACHE (little headache the second day) outcome was unknown.            No treatment was mentioned. No Concomitants are mentioned.   This case was linked to MOD-2021-014749 (Patient Link).